# A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula

> **NCT03438266** · NA · COMPLETED · sponsor: **Allergan** · enrollment: 66 (actual)

## Conditions studied

- Age-related Volume Deficit in the Mid-face

## Interventions

- **DEVICE:** JUVÉDERM VOLUMA® XC injectable gel with cannula
- **DEVICE:** JUVÉDERM VOLUMA® XC injectable gel with needle

## Key facts

- **NCT ID:** NCT03438266
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-05
- **Primary completion:** 2018-05-29
- **Final completion:** 2018-08-02
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2019-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03438266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03438266, "A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT03438266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*